According to Onconova Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 21,002,937. At the end of 2023 the company had 21,002,937 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 21 M | 0.42% |
2022 | 20.91 M | 30.89% |
2021 | 15.97 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Baxter BAX | 507,000,000 | 2,313.95% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | 201,918,066 | 861.38% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | 131,566,000 | 526.42% | ๐บ๐ธ USA |
Cleveland BioLabs
CBLI | 12,919,100 | -38.49% | ๐บ๐ธ USA |
Array Technologies ARRY | 151,175,000 | 619.78% | ๐บ๐ธ USA |